隐球菌病的一级预防对念珠菌属中氟康唑耐药性的影响。 - Suppr

Suppr

超能文献

The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species.

作者信息

Apisarnthanarak Anucha, Mundy Linda M

出版信息

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):644-5. doi: 10.1097/QAI.0b013e31815bad0c.

DOI:10.1097/QAI.0b013e31815bad0c

PMID:18362695

Abstract

摘要

相似文献

The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species.

J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):644-5. doi: 10.1097/QAI.0b013e31815bad0c.

Current approach to the acute management of cryptococcal infections.

J Infect. 2000 Jul;41(1):18-22. doi: 10.1053/jinf.2000.0696.

The hidden danger of primary fluconazole prophylaxis for patients with AIDS.

Clin Infect Dis. 1998 Jan;26(1):186-7. doi: 10.1086/517056.

Cessation of secondary prophylaxis in patients with cryptococcosis.

AIDS. 2001 Jul 27;15(11):1438-9. doi: 10.1097/00002030-200107270-00015.

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.

Clin Infect Dis. 2001 Oct 1;33(7):1069-75. doi: 10.1086/322641. Epub 2001 Sep 5.

Primary Prophylaxis for Cryptococcosis With Fluconazole in Human Immunodeficiency Virus-Infected Patients With CD4 T-Cell Counts <100 Cells/µL and Receiving Antiretroviral Therapy.

Clin Infect Dis. 2017 Apr 1;64(7):967-970. doi: 10.1093/cid/cix036.

Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy.

AIDS. 2001 Jul 27;15(11):1448-9. doi: 10.1097/00002030-200107270-00019.

Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.

PLoS One. 2010 Nov 9;5(11):e13856. doi: 10.1371/journal.pone.0013856.

[Desensitization to fluconazole in patient with human inmunodeficiency virus infection].

Med Clin (Barc). 2002 Jun 15;119(2):77. doi: 10.1016/s0025-7753(02)73321-6.

[Therapy of candidiasis and cryptococcosis in AIDS].

Mycoses. 1994;37 Suppl 2:56-63.

引用本文的文献

Uptake of lumbar puncture and mortality among patients with advanced human immunodeficiency virus disease who screened for serum cryptococcal-antigen in Africa.

World J Virol. 2025 Jun 25;14(2):106973. doi: 10.5501/wjv.v14.i2.106973.

Primary antifungal prophylaxis for cryptococcal disease in HIV-positive people.

Cochrane Database Syst Rev. 2018 Aug 29;8(8):CD004773. doi: 10.1002/14651858.CD004773.pub3.

Cryptococcal meningitis: epidemiology and therapeutic options.

Clin Epidemiol. 2014 May 13;6:169-82. doi: 10.2147/CLEP.S38850. eCollection 2014.

Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.

PLoS One. 2013 Jul 19;8(7):e69288. doi: 10.1371/journal.pone.0069288. Print 2013.

Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.

Expert Rev Anti Infect Ther. 2011 Apr;9(4):415-30. doi: 10.1586/eri.11.21.

Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.

Antimicrob Agents Chemother. 2011 Jun;55(6):2606-11. doi: 10.1128/AAC.00048-11. Epub 2011 Mar 28.

Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia.

PLoS One. 2010 Nov 9;5(11):e13856. doi: 10.1371/journal.pone.0013856.

Treatment of cryptococcal meningitis in resource limited settings.

Curr Opin Infect Dis. 2009 Oct;22(5):455-63. doi: 10.1097/QCO.0b013e32832fa214.

Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Clin Infect Dis. 2009 Apr 1;48(7):856-62. doi: 10.1086/597262.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验